Showing results (291-300 of 309) with videos related to
Sort By:
Pageof 31
Molecular Urology|November 4, 2000
Three-dimensional ultrasound analyses of the prostateE J Feleppa, W R Fair, T Liu, et al.The Journal of Urology|April 1, 1989
Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethraP R Bretton, H W Herr, W F Whitmore, et al.The Journal of Urology|July 1, 1987
Fertility status of patients with clinical stage I testis tumors on a surveillance protocolP R Carroll, M J Morse, W F Whitmore, et al.The Journal of Urology|February 1, 1990
Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformationJ Sheinfeld, V E Reuter, M R Melamed, et al.Histology and Histopathology|May 16, 2000
Expression of c-kit and kit-ligand in benign and malignant prostatic tissuesR Simak, P Capodieci, D W Cohen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-upP K Schultz, H W Herr, Z F Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional studyD F Bajorin, M F Sarosdy, D G Pfister, et al.Critical Reviews in Oncology/Hematology|February 1, 1994
Bladder cancer: advances in biology and treatmentG J Bosl, W R Fair, H W Herr, et al.The Journal of Urology|March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumorsH I Scher, A Yagoda, H W Herr, et al.The American Journal of Medicine|March 1, 1980
High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activityE Frei, R H Blum, S W Pitman, et al.Pageof 31